Difference between revisions of "Pharm Tech Minutes 2014.06.12"
Jump to navigation
Jump to search
Michael tan (talk | contribs) |
|||
Line 1: | Line 1: | ||
=09:30 - 09:45 Welcome= | =09:30 - 09:45 Welcome= | ||
*Participants | *Participants | ||
− | ** Juergen Brandstaetter (Codewerk, Austria) | + | ** Hosts and guests |
− | ** Michael Tan (Nictiz, Netherlands) | + | *** Ricardo João Cruz Correia (University of Porto, Host) |
− | ** Simon Letellier (EAHP, France) | + | *** Sebastiao Ferreira da Silva (University of Porto, Host) |
− | ** Jose Costa Teixeira (Portugal) | + | *** Pedro Manuel Viera Marques (Med.up., Portugal) |
− | ** Jacqueline Surugue ( | + | *** Ines Vaz (Med.up.Portugal) |
− | ** Christof Gessner (Gematik, Germany) | + | *** Jose Hilario Almeida (Portugal) |
− | ** Sylvia Thun (University of Applied Sciences | + | |
− | + | ** IHE | |
− | + | *** Juergen Brandstaetter (Codewerk, Austria) | |
− | + | *** Michael Tan (Nictiz, Netherlands) | |
− | + | *** Simon Letellier (EAHP, France) | |
− | + | *** Jose Costa Teixeira (Portugal) | |
+ | *** Jacqueline Surugue (EAHP, France) | ||
+ | *** Christof Gessner (IHE Deutschland, Gematik, Germany) | ||
+ | *** Sylvia Thun (IHE Deutschland , Niederrhein University of Applied Sciences, Germany) | ||
+ | |||
*Review and Approve Agenda | *Review and Approve Agenda |
Revision as of 04:27, 23 June 2014
09:30 - 09:45 Welcome
- Participants
- Hosts and guests
- Ricardo João Cruz Correia (University of Porto, Host)
- Sebastiao Ferreira da Silva (University of Porto, Host)
- Pedro Manuel Viera Marques (Med.up., Portugal)
- Ines Vaz (Med.up.Portugal)
- Jose Hilario Almeida (Portugal)
- Hosts and guests
- IHE
- Juergen Brandstaetter (Codewerk, Austria)
- Michael Tan (Nictiz, Netherlands)
- Simon Letellier (EAHP, France)
- Jose Costa Teixeira (Portugal)
- Jacqueline Surugue (EAHP, France)
- Christof Gessner (IHE Deutschland, Gematik, Germany)
- Sylvia Thun (IHE Deutschland , Niederrhein University of Applied Sciences, Germany)
- IHE
- Review and Approve Agenda
- Approved
- Approval of minutes of TCon May 22, 2014
09:45 - 13:30 CP processing
- The following (simple) CPs have been summarized:
- CP-PHARM-068, Add more samples to Active Ingredient structure
- CP-PHARM-069, Add terms to glossary
- CP-PHARM-070, Align Purpose and Scope to Glossary
- CP-PHARM-071, Improve definition of "Patient instructions" and "Fulfillment instructions"
- CP-PHARM-072, Pharmacy Common Editorial Changes
- CP-PHARM-075, Clarify meaning of statusCode
- CP-PHARM-076, Renaming of chapters to align to naming policy
- CP-PHARM-077, Adding Narrative Text element to supply element
- CP-PHARM-079, Added missing “Specialty” to Data Element Specification
- CP-PHARM-080, Correction to CP-PHARM-046 and CP-PHARM-047
- CP-PHARM-081, Improve descriptions of Documents, Sections and Entries
- Motion: Approve above block of CPs as "Approved for ballot"
- Approved (071, 076 with changes)
- The following (complex) CPs have been reviewed:
- CP-PHARM-063, Introduce a “Dosing Information” Content Module and restructure the PRE, PADV, DIS documents to reference this Content Module for Dosing Information
- Postponed to next day
- CP-PHARM-065, Enhance Medication packaging structure (asSuperContent, expirationTime) and relocate lotNumber parallel to expirationTime
- Approved with changes
- CP-PHARM-066, Add new status: "SUSPEND"
- Approved with changes
- CP-PHARM-067, Clarify meaning of "Amounts of consumable to be dispensed" and "Quantity supplied" in the context of medicinal products containing multiple active ingredients
- Approved with changes
- CP-PHARM-073, Make PADV capable to record also other kind of concerns than just ones caused by other Prescription-/ or Dispense items (e.g., by Allergy, etc.)
- Approved with changes
- CP-PHARM-074, Introduce effectiveTime to specify the time the “code” (e.g. CANCEL) of the PADV shall become effective
- Approved with changes
- CP-PHARM-078, Adding Code element to supply element to indicate whether this Dispensation Item is “partially” or “fully” fulfilling an underlying Prescription Item
- Approved with changes
- CP-PHARM-082, Add Pharmaceutical Adviser / Dispenser at section level (to be consistent with PRE)
- Approved with changes
- CP-PHARM-083, Add additional constraints to underlying PCC Medications template
- Approved
- CP-PHARM-084, Add additional constraints to underlying PCC Supply template
- Approved
- CP-PHARM-085, Lower constraint for referenced PADV from SHALL to SHALL IF KNOWN
- Approved with changes
- An overview about all Pharmacy CPs is located at: ftp://ftp.ihe.net/Pharmacy/Technical_Framework/CP%20Overview/CP%20Overview.xlsx
13:30 - 14:30 Lunch
14:30 - 15:15 CP processing (continued)
- See CPs above
- Discussion about the topic, if term "dose form" or "dosage form" is correct
- Outcome:
- John Hatem: Both terms are used and equivalent, but only if used in combination with "form" (not dose or dosage alone)
- FDA uses dosage form
- Europe: EMA uses dose form
- Australia/UK use dose form
- Decision: Since both terms are equivalent we keep "dose form" in our profiles
17:00 - 18:00 Update on Healthcare Product Supply Interoperability (Jose, Syliva Thun)
- Presentation of Sylvia Thun
- []